Geron (GERN) EBITDA Margin (2010 - 2026)

Geron has disclosed EBITDA Margin across 17 years of filings, most recently posting 0.3% for Q1 2026.

• EBITDA Margin for Q1 2026 came in at 0.3%, up 4248.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 100.0% (up 1598.0% YoY), and the FY2025 annual result was 173.68%, up 5342.0% from the prior year.
• EBITDA Margin came in at 0.3% for Q1 2026 at Geron, down from 26.5% in the prior quarter.
• In the past five years, EBITDA Margin ranged from a high of 25368.69% in Q4 2023 to a low of 190914.29% in Q1 2023.
• The 5-year median for EBITDA Margin is 99.8% (2024), against an average of 27460.87%.
• Across the five-year window, EBITDA Margin tumbled 16760128 bps in 2023 and soared 17244915 bps in 2024, its largest moves.
• Geron's EBITDA Margin stood at 8509.33% in 2022, then surged by 198 bps to 25368.69% in 2023, then plunged by 100 bps to 42.62% in 2024, then surged by 162 bps to 26.5% in 2025, then tumbled by 99 bps to 0.3% in 2026.
• The last three EBITDA Margin figures came in at 0.3% (Q1 2026), 26.5% (Q4 2025), and 29.4% (Q3 2025), per Business Quant data.